证券代码：300341 证券简称：麦克奥迪 公告编号：2023-043 麦克奥迪（厦门）电气股份有限公司 第五届董事会第二次会议决议公告 1、审议通过《<2023 年半年度报告>及<2023 年半年度报告摘要>》的议案 公司董事认真审阅了《麦克奥迪(厦门)电气股份有限公司 2023 年半年度报 告》全文及摘要，该报告的编制和审议程序符合法律法规、规范性文件以及公司 章程的规定，其内容与格式符合中国证监会和深圳证券交易所的各项规定，报告 内容真实、准确和完整地反映了公司 2023 年上半年度的财务状况和经营成果。 公司独立董事就控股股东及其他关联方占用公司资金、公司对外担保情况发 表了独立意见。 （以上议案同意票 12 票、反对票 0 票、弃权票 0 票） 2、审议通过《关于新增 2023 年度日常关联交易预计的议案》 《麦克奥迪：关于新增 2023 年度日常关联交易预计的公告》详见中国证监 会指定的创业板信息披露网站。 公司独立董事对此项议案发表了事前认可意见及同意意见。 本公司及董事会全体成员保证信息披露内容的真实、准确和完 整，没有虚假记载、误导性陈述或重大遗漏。 一、会议出席情况： 麦克奥迪（厦门）电气 ...

证券代码：300341 证券简称：麦克奥迪 公告编号：2023-044 麦克奥迪（厦门）电气股份有限公司 第五届监事会第二次会议决议公告 本公司及监事会全体成员保证信息披露内容的真实、准确和完 整，没有虚假记载、误导性陈述或重大遗漏。 一、会议出席情况 1、审议通过关于公司《<2023年半年度报告>及<2023年半年度报告摘要>》 的议案 公司监事会对公司董事会编制完成的公司《<2023 年半年度报告>及<2023 年 半年度报告摘要>》进行了认真的审阅，并提出如下审核意见： （1）公司《<2023 年半年度报告>及<2023 年半年度报告摘要>》的编制和审 议程序符合法律法规、规范性文件以及公司章程和公司内部管理制度的各项规定； （2）公司《<2023 年半年度报告>及<2023 年半年度报告摘要>》的内容和格 式符合中国证监会和深圳证券交易所的各项规定，所包含的信息能从各个方面真 实准确反映公司 2023 年上半年度的财务状况和经营成果等事项； （3）在公司监事会提出本意见前，未发现参与公司《<2023 年半年度报告> 及<2023 年半年度报告摘要>》编制和审议的人员有违反保密规定的行为。 基于上述审核 ...

关于麦克奥迪（厦门）电气股份有限公司 第五届董事会第二次会议相关事项的事前认可意见 根据《上市公司独立董事规则》《上市公司治理准则》《深圳证券交易所上市公司自 律监管指引第2号——创业板上市公司规范运作》《深圳证券交易所创业板股票上市规则》 等有关文件规定，以及《公司章程》《独立董事制度》等公司制度的约定，我们作为麦克 奥迪（厦门）电气股份有限公司（以下简称"公司"）的独立董事，基于客观、独立判断 的立场，就公司第五届董事会第二次会议相关事项进行了事前审核，发表事前认可意见如 下： 一、关于新增 2023 年度日常关联交易预计的认可意见 公司本次新增 2023 年度日常关联交易预计金额事项系公司控股子公司业务发 展需要，按照自愿、公开、公平、诚信的原则进行，关联交易的价格按照公平合理 的原则协商确定，不构成对公司独立性的影响，不会造成对公司及股东利益的损害。 因此，我们对公司新增 2023 年度日常关联交易预计的相关内容表示认可，并同意 将《关于新增 2023 年度日常关联交易预计的议案》 提交公司第五届董事会第二次 会议审议，与本次交易有关联关系的董事应回避表决。 (此页无正文,为《麦克奥迪(厦门)电气股份 ...

麦克奥迪（厦门）电气股份有限公司 独立董事关于第五届董事会第二次会议相关事项的独立意见 我们作为麦克奥迪(厦门)电气股份有限公司(以下简称"公司")的独立董事，根据《上 市公司独立董事规则》《深圳证券交易所上市公司自律监管指引第2号——创业板上市公司 规范运作》及《麦克奥迪(厦门)电气股份有限公司章程》《公司独立董事工作制度》等相关 法律法规、规章制度的有关规定，认真查阅了公司董事会提供的相关资料，并基于自身的独 立判断，对公司第五届董事会第二次会议相关事项发表如下独立意见: 一、关于公司2023年半年度控股股东及其他关联方资金占用情况、公司对外担保情况的 独立意见 公司新增2023年预计日常关联交易是属公司正常业务范围，符合公司实际情况，没有损 害公司和其他非关联股东的利益。我们同意前述交易。有关关联交易董事会审议事项和表决 程序符合《股票上市规则》和《公司章程》的规定，关联董事回避表决，程序合法。 (此页无正文,为《麦克奥迪(厦门)电气股份有限公司独立董事关于第五届董事会第二次 会议相关事项的独立意见》的签字页) 我们对报告期内公司控股股东及其他关联方占用公司资金和对外担保情况进行了认真 的核查，现发表专 ...

关于新增2023年度日常关联交易预计的公告 证券代码：300341 证券简称：麦克奥迪 公告编号：2023-042 麦克奥迪（厦门）电气股份有限公司 2、根据公司及其控股子公司日常经营实际需要，结合 2023 年度公司关联交 易的实际情况和公司业务发展的需要，公司 2023 年新增与关联方发生日常关联 交易预计总额不超过人民币 4,349.00 万元。2023 年 08 月 25 日，公司第五届董 事会第二次会议审议通过了《关于新增 2023 年度日常关联交易预计的议案》， 关联董事回避表决，独立董事已经事前认可并发表了独立意见。根据《深圳证券 交易所创业板股票上市规则》和《公司章程》等相关规定，本次新增日常关联交 易预计金额后，按照受同一主体控制的关联人合并累计计算，未超过公司最近一 期经审计净资产额 5%以上，本次关联交易预计事项在董事会审议权限范围内， 无需提交股东大会审议，且不构成《上市公司重大资产重组管理办法》规定的重 大资产重组。 （二）预计关联交易类别和金额 1 新增 2023 年度公司与关联方的日常关联交易的预计情况如下： （三）预计关联交易类别和金额 上一年度日常关联交易实际发生情况： 公司 ...

相关信息需经优纳同意才能对外公开，感谢您的关注！ 证券代码： 300341 证券简称：麦克奥迪 麦克奥迪(厦门)电气股份有限公司投资者关系活动记录表 | 投资者关系活动 | □特定对象调研 □ 分析师会议 | | --- | --- | | 类别 | □ 媒体采访 √ 业绩说明会 | | | □ 新闻发布会 □ 路演活动 | | | 现场参观 □ | | | 其他 （请文字说明其他活动内容） □ | | 参与单位名称及 | 投资者网上提问 | | 人员姓名 | | | 时间 | 2023 年 5 月 12 日 (周五) 下午 14:30~17:15 | | 地点 | 公司通过全景网"投资者关系互动平台"（https://ir.p5w.net） | | | 采用网络远程的方式召开业绩说明会 | | 上市公司接待人 | 1、监事陈培堃 | | 员姓名 | 2、财务副总监刘亚军 | | | 3、董事长杨文良 | | | 4、副总经理兼董事会秘书李臻 | | | 5、独立董事肖伟 投资者提出的问题及公司回复情况 | | | 公司就投资者在本次说明会中提出的问题进行了回复： 1、麦克奥迪是厦门上市公司，有没有打算搬迁到 ...

证券代码：300341 证券简称：麦克奥迪 公告编号：2023-020 麦克奥迪（厦门）电气股份有限公司 关于参加厦门辖区上市公司 2023 年投资者 网上集体接待日活动的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 为进一步加强与广大投资者的沟通和交流，麦克奥迪（厦门）电气股份有限 公司（以下简称"公司"）将参加由厦门证监局、厦门上市公司协会与深圳市全景 网络有限公司联合举办的"2023 年厦门辖区上市公司投资者网上集体接待日活 动"（以下简称"本次活动"），现将相关事项公告如下： 一、召开时间 2023 年 5 月 12 日（星期五）14:30－16:15 二、召开方式 本次活动将采用网络远程的方式举行，投资者可登录"全景路演"网站 （http://rs.p5w.net），或关注微信公众号：全景财经，或下载全景路演 APP，参与 本次互动交流。 三、出席活动的人员 公司出席本次活动的人员有：公司董事长杨文良先生、副总经理兼董事会秘 书李臻先生、财务副总监刘亚军先生、监事陈培堃先生。 四、投资者问题征集及方式 为进一步做好中小投资者保护工作，充分尊重 ...

Financial Performance - The company's operating revenue for Q1 2023 was ¥348,643,873.82, a decrease of 3.02% compared to ¥359,515,780.05 in the same period last year[4] - Net profit attributable to shareholders was ¥38,942,232.67, down 14.62% from ¥45,610,282.01 year-on-year[4] - Basic and diluted earnings per share decreased by 15.10% to ¥0.0759 from ¥0.0894 in the same period last year[4] - Total operating revenue for Q1 2023 was CNY 348,643,873.82, a decrease of 3.4% compared to CNY 359,515,780.05 in Q1 2022[17] - Net profit for Q1 2023 was CNY 40,564,635.86, down 14.6% from CNY 47,191,169.22 in Q1 2022[19] - Earnings per share for Q1 2023 were CNY 0.0759, compared to CNY 0.0894 in the same period last year, reflecting a decline of 15.6%[20] - The company recorded a comprehensive income of CNY 32,129,339.87 for Q1 2023, down from CNY 44,069,776.67 in the same period last year[20] Cash Flow - The net cash flow from operating activities increased significantly by 316.07% to ¥59,298,306.46, compared to ¥14,251,925.13 in the previous year[4] - The company reported a net increase in cash flow from operating activities due to increased collections from receivables in the medical segment[9] - The net cash flow from operating activities for Q1 2023 was ¥59,298,306.46, a significant increase from ¥14,251,925.13 in Q1 2022, representing a growth of approximately 317%[23] - Cash inflow from operating activities increased to CNY 420,542,720.06 in Q1 2023, up from CNY 340,370,457.92 in Q1 2022, representing a growth of 23.6%[22] - The company reported a total cash outflow from operating activities of ¥361,244,413.60, which is higher than ¥326,118,532.79 in the previous year, indicating increased operational expenses[23] Assets and Liabilities - Total assets at the end of the reporting period were ¥2,231,418,082.18, a slight increase of 0.03% from ¥2,230,637,587.80 at the end of the previous year[4] - The company's equity attributable to shareholders increased by 2.36% to ¥1,591,989,303.98 from ¥1,555,240,324.80 at the end of the previous year[4] - Total liabilities as of Q1 2023 were CNY 506,217,833.55, down from CNY 538,857,604.09 in the previous year[19] - Current liabilities decreased to ¥473,065,289.90 from ¥505,000,513.29, a reduction of approximately 6.31%[15] - Non-current assets total ¥583,542,857.19, up from ¥574,666,106.22, indicating an increase of about 1.52%[15] Investments - The company’s investment activities generated a net cash outflow of ¥40,998,500, a decrease of 4,416,230 compared to the previous year, mainly due to investments in the renovation of the second phase of the factory[9] - Total cash outflow from investing activities was ¥41,001,003.82, compared to ¥17,288,954.07 in the previous year, indicating a year-over-year increase of about 137.5%[23] - The net cash flow from investing activities was -¥40,998,482.71, a decline from a positive cash flow of ¥3,163,795.93 in Q1 2022[23] Shareholder Information - Total number of common stock shareholders at the end of the reporting period is 21,520[11] - The largest shareholder, Beijing Yizhuang Investment Holding Co., Ltd., holds 29.80% of shares, totaling 152,997,984 shares[11] Other Financial Metrics - The company experienced a decrease in financial expenses by ¥6,222,400, primarily due to the impact of the continuous depreciation of the RMB[8] - The company has a long-term investment of ¥3,428,447.14, down from ¥3,667,581.63, a decrease of approximately 6.53%[15] - Research and development expenses for Q1 2023 were CNY 14,379,974.40, a decrease of 6.4% from CNY 15,361,562.74 in Q1 2022[17] - The company reported a financial expense of CNY -3,515,470.42 in Q1 2023, a significant improvement compared to CNY 2,706,932.75 in Q1 2022[19] - The cash inflow from other financing activities was ¥855,000.00, a decrease from ¥1,400,000.00 in Q1 2022, indicating a reduction in external financing sources[23] Strategic Initiatives - The company is actively exploring new product development and market expansion strategies, although specific details were not disclosed in the report[12] Audit Information - The company did not conduct an audit for the Q1 2023 report, as stated in the audit report[24]

Financial Performance - The company's operating revenue for 2022 was CNY 1,793,966,267, representing a 22.48% increase compared to CNY 1,464,754,511 in 2021[26]. - Net profit attributable to shareholders for 2022 was CNY 261,140,467, a 46.68% increase from CNY 178,037,346 in 2021[26]. - The basic earnings per share for 2022 was CNY 0.5100, up 46.13% from CNY 0.3490 in 2021[26]. - The total assets at the end of 2022 reached CNY 2,230,637,578, marking a 19.77% increase from CNY 1,861,536,920 at the end of 2021[26]. - The net cash flow from operating activities for 2022 was CNY 239,499,904, a slight increase of 2.19% from CNY 234,367,769 in 2021[26]. - The company achieved a total revenue of 1,793.97 million yuan in 2022, representing a year-on-year growth of 22.48%[47]. - The net profit attributable to shareholders was 261.14 million yuan, an increase of 46.68% compared to the previous year[47]. - Basic earnings per share rose to 0.5100 yuan, reflecting a growth of 46.13% year-on-year[47]. Dividend Policy - The company plans to distribute a cash dividend of 1.1 RMB per 10 shares to all shareholders, based on a total of 513,393,236 shares[6]. - The company plans to distribute a cash dividend of ¥1.1 per 10 shares, totaling ¥56,473,255.96, which represents 100% of the profit distribution amount[164]. - The company’s cash dividend policy stipulates that at least 20% of the distributable profit should be allocated as cash dividends if there are significant capital expenditure arrangements[161]. - The company’s profit distribution plan must be approved by the board and the shareholders' meeting, ensuring independent directors and minority shareholders have a voice[163]. Operational Risks and Management - The company emphasizes the importance of risk awareness regarding future operational plans and performance forecasts, indicating that these do not constitute commitments to investors[3]. - The company has disclosed potential operational risks and corresponding countermeasures in the management discussion and analysis section[4]. - The company is focusing on enhancing operational efficiency and reducing costs through strategic planning and internal restructuring in response to global uncertainties[48]. - The company recognizes the risk of technology updates and product development, emphasizing the need for continuous innovation and market responsiveness[108]. Business Segments and Growth Areas - The company operates in three core business areas: medical business, optoelectronic business, and smart electrical business, focusing on integrated innovation to drive industrial upgrades[42]. - The medical business includes digital pathology scanning and application systems, remote expert diagnostic services, and AI-assisted diagnostic products, covering over 2,500 medical institutions nationwide[43]. - The optoelectronic business is experiencing rapid growth, with domestic manufacturers increasingly replacing imports in the microscope industry, driven by advancements in precision manufacturing[39]. - The smart electrical business is benefiting from the increasing market size of the high-voltage switch industry, providing a broad market space for epoxy insulation products[41]. Research and Development - The company is focusing on R&D projects aimed at enhancing product intelligence and performance, including the development of high-strength epoxy resin formulations and new production processes for high-voltage insulation components[77]. - The company is investing in research and development to introduce innovative solutions that align with market demands and consumer preferences[128]. - The company has obtained 13 invention patents, 11 utility model patents, and 17 software copyrights in the medical business sector, showcasing its commitment to innovation[57]. - The company is developing a high-throughput digital slice scanner to meet the increasing demands of large hospitals and third-party diagnostic institutions[78]. Market Expansion and Strategy - The company plans to expand its applications in precision instruments for industrial inspection and scientific research in 2023, focusing on sectors such as new energy, electronics, and biomedicine[44]. - The company plans to expand its market presence through strategic partnerships and potential acquisitions to enhance growth opportunities[128]. - Market expansion plans include entering two new international markets by Q3 2023, targeting a 5% increase in overall market share[133]. Corporate Governance - The company has established a complete and independent business system, ensuring autonomy in operations and decision-making[120]. - The board of directors consists of 12 members, including 4 independent directors, complying with legal and regulatory requirements[114]. - The company has a robust internal control system that meets national legal requirements and effectively mitigates operational risks[118]. - The company has established a transparent information disclosure system, ensuring timely and accurate communication with investors[118]. Environmental and Social Responsibility - The company is committed to environmental protection and aims to establish a low-carbon electrical industrial park in Xiamen[185]. - The company actively participates in social responsibility initiatives, including virus prevention and employee health protection during the reporting period[186]. - The company emphasizes the protection of investor rights, particularly for small and medium investors, by enhancing corporate governance and compliance with regulations[185]. Financial Management and Audit - The company has maintained a complete and independent financial management system, with separate bank accounts and independent tax obligations[121]. - The domestic accounting firm, Rongcheng CPA, has been engaged for 4 consecutive years, with an audit fee of 1.8 million yuan[198]. - The company has not changed its accounting firm, indicating stability in its financial reporting practices[198]. Employee and Talent Management - The total number of employees at the end of the reporting period was 2,136, with 1,090 in production, 224 in sales, and 320 in technical roles[153]. - The company has established a three-year shareholder return plan (2021-2023) to ensure a stable and scientific dividend distribution mechanism[158]. - The company plans to further enhance its talent training system in 2023, leveraging internal resources to foster a learning-oriented environment[156].

麦克奥迪(厦门)电气股份有限公司（以下简称"公司"）已于 2023 年 04 月 11 日在巨潮资讯网上披露了《2022 年度报告全文》及《2022 年度报告摘要》。 为便于广大投资者更加全面深入地了解公司经营业绩、发展战略等情况，公司定 于 2023 年 04 月 28 日（星期五）15:00-17:00 在"价值在线"（www.ir-online.cn） 举办麦克奥迪(厦门)电气股份有限公司 2022 年度业绩说明会，与投资者进行沟 会议召开时间：2023 年 04 月 28 日（星期五）15:00-17:00 会议召开方式：网络互动方式 会议召开地点：价值在线（www.ir-online.cn） 会议问题征集： 投 资 者 可 于 2023 年 04 月 28 日 前 访 问 网 址 https://eseb.cn/13Ie5sFtYDS 或使用微信扫描下方小程序码进行会前提 问，公司将通过本次业绩说明会，在信息披露允许范围内就投资者普遍 关注的问题进行回答。 通和交流，广泛听取投资者的意见和建议。 一、说明会召开的时间、地点和方式 会议召开时间：2023 年 04 月 28 日（星期五）15:00-1 ...